Showing results (2801-2810 of 9,924) with videos related to
Sort By:
Pageof 993
Bone Marrow Transplantation|October 18, 2019
Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseasesKevin Hendrawan, Malini Visweswaran, David D F Ma, et al.Bone Marrow Transplantation|May 16, 2019
Cord blood research, banking, and transplantation: achievements, challenges, and perspectivesHector Mayani, John E Wagner, Hal E BroxmeyerBone Marrow Transplantation|October 17, 2019
Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countriesIbrahim N Muhsen, Shahrukh K Hashmi, Dietger Niederwieser, et al.Bone Marrow Transplantation|April 23, 2022
Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMTMitja Nabergoj, Katya Mauff, Dietrich Beelen, et al.Bone Marrow Transplantation|April 28, 2022
CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosisMariam T Nawas, Jeong-Ok Lee, Jessica Flynn, et al.Bone Marrow Transplantation|April 19, 2022
Safety analysis of patients who received ruxolitinib for steroid-refractory acute or chronic graft-versus-host disease in an expanded access programMark A Schroeder, Parameswaran N Hari, Amy Blithe, et al.Bone Marrow Transplantation|October 20, 2021
Cognitive impairment in candidates for allogeneic hematopoietic stem cell transplantationPatrick J Smith, Meagan Lew, Yen Lowder, et al.Bone Marrow Transplantation|January 30, 2022
Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphomaRaphaël Liévin, Roberta Di Blasi, Florence Morin, et al.Bone Marrow Transplantation|October 17, 2021
Cancers after HLA-matched related bone marrow transplantation for aplastic anemiaPhuong Vo, Lynn Onstad, Mary E Flowers, et al.Bone Marrow Transplantation|October 2, 2021
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMTStavroula Masouridi-Levrat, Eduardo Olavarria, Simona Iacobelli, et al.Pageof 993